The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving hepatitis B virus (HBV) cure in the presence or absence of human immunodeficiency virus (HIV).
Deadlines:
- R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
- AIDS Application Due Date(s): Jan. 7, May 7, Sep. 7
PAS-19-097 Expiration Date January 08, 2022
Amount Description